Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
4.350
-0.040 (-0.91%)
At close: Oct 16, 2026, 4:00 PM EDT
4.360
+0.010 (0.23%)
After-hours: Oct 16, 2026, 7:30 PM EDT
Cingulate Market Cap
Cingulate has a market cap or net worth of $63.4 million as of October 16, 2026. It is the 28,532nd most valuable company in the world and the 4,465th biggest in the United States. Its market cap has increased by 182.74% in one year.
Market Cap
63.40M
Enterprise Value
41.29M
1-Year Change
182.74%
Global Rank
Country Rank
#4,465 United States
Category
ChartMarket Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $63.40M, a decrease of -1.37%. That is a compound annual growth rate of -0.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 63.40M | 116.20% |
| Dec 31, 2025 | 29.33M | 80.15% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeOnc Technologies Holdings | 67.11M |
| MAIA Biotechnology | 66.91M |
| Champions Oncology | 65.42M |
| XBiotech | 64.63M |
| Spero Therapeutics | 64.06M |
| Oncolytics Biotech | 63.51M |
| Biomea Fusion | 62.98M |
| Fortress Biotech | 62.37M |